Q1 2016 Holdings
Filed 2016-05-13 | 32 holdings | $96.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celgene Corp(CELG) | COM | 151020104 | $13.5K | 135,000 | 14.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $13.1K | 76,200 | 13.6% |
| Pfizer Inc(PFE) | COM | 717081103 | $12.9K | 436,000 | 13.4% |
| Allergan plc | SHS | G0177J108 | $7.4K | 27,500 | 7.6% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $6.5K | 101,000 | 6.7% |
| Mylan NV | SHS EURO | N59465109 | $6.3K | 136,000 | 6.5% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $4.7K | 117,000 | 4.9% |
| Horizon Pharma Plc | SHS | G4617B105 | $3.6K | 220,000 | 3.8% |
| Seattle Genetics Inc | COM | 812578102 | $3.6K | 103,000 | 3.7% |
| Lannett Inc | COM | 516012101 | $2.7K | 150,000 | 2.8% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $2.5K | 183,000 | 2.6% |
| Exelixis Inc | NOTE 4.250% 8/1 | 30161QAC8 | $2.0K | $2,000,000 | 2.1% |
| ImmunoGen Inc(IMGNEUR) | COM | 45253H101 | $1.9K | 228,000 | 2.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.7K | 117,000 | 1.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.7K | 42,000 | 1.7% |
| UniQure NV(QURE) | SHS | N90064101 | $1.4K | 115,000 | 1.4% |
| Eagle Pharmaceuticals Inc(EGRX)Put | COM | 269796108 | $1.3K | 33,000 | 1.4% |
| Immune Design Corp | COM | 45252L103 | $1.1K | 85,138 | 1.1% |
| Ignyta Inc | COM | 451731103 | $1.0K | 150,000 | 1.1% |
| Neuroderm Ltd | ORD SHS | M74231107 | $988 | 70,000 | 1.0% |
| Advaxis Inc | COM NEW | 007624208 | $903 | 100,000 | 0.9% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $813 | 20,000 | 0.8% |
| Lion Biotechnologies Inc | COM | 53619R102 | $774 | 152,266 | 0.8% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $764 | 145,000 | 0.8% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $733 | 60,280 | 0.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $507 | 40,000 | 0.5% |
| Progenics Pharmaceuticals In | COM | 743187106 | $419 | 96,000 | 0.4% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $401 | 33,716 | 0.4% |
| BioPharmX Corp | COM | 09072X101 | $377 | 345,440 | 0.4% |
| Tobira Therapeutics Inc | COM | 88883P101 | $368 | 45,000 | 0.4% |
| XenoPort Inc | COM | 98411C100 | $361 | 80,000 | 0.4% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $209 | 34,100 | 0.2% |